Axcelis Technologies, Inc. $ACLS Stock Sold by Boston Trust Walden Corp

Boston Trust Walden Corp lessened its holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 5.2% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 340,419 shares of the semiconductor company’s stock after selling 18,837 shares during the period. Boston Trust Walden Corp’s holdings in Axcelis Technologies were worth $44,656,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. ARGA Investment Management LP lifted its position in shares of Axcelis Technologies by 68.7% during the 3rd quarter. ARGA Investment Management LP now owns 25,110 shares of the semiconductor company’s stock worth $3,294,000 after purchasing an additional 10,229 shares during the last quarter. Vise Technologies Inc. acquired a new position in shares of Axcelis Technologies during the third quarter worth $308,000. BOKF NA increased its holdings in Axcelis Technologies by 56.5% in the third quarter. BOKF NA now owns 6,521 shares of the semiconductor company’s stock valued at $855,000 after buying an additional 2,355 shares during the last quarter. Peterson Wealth Services increased its holdings in Axcelis Technologies by 6.1% in the third quarter. Peterson Wealth Services now owns 9,751 shares of the semiconductor company’s stock valued at $1,279,000 after buying an additional 560 shares during the last quarter. Finally, Sterling Capital Management LLC increased its holdings in Axcelis Technologies by 840.9% in the third quarter. Sterling Capital Management LLC now owns 1,035 shares of the semiconductor company’s stock valued at $136,000 after buying an additional 925 shares during the last quarter. Institutional investors and hedge funds own 89.98% of the company’s stock.

Axcelis Technologies Stock Down 5.4%

Axcelis Technologies stock opened at $92.14 on Thursday. The stock has a 50 day moving average of $116.69 and a two-hundred day moving average of $122.67. Axcelis Technologies, Inc. has a twelve month low of $73.60 and a twelve month high of $193.78. The stock has a market capitalization of $2.85 billion, a price-to-earnings ratio of 24.91, a PEG ratio of 2.97 and a beta of 1.88. The company has a current ratio of 4.90, a quick ratio of 3.21 and a debt-to-equity ratio of 0.04.

Axcelis Technologies (NASDAQ:ACLS) last released its earnings results on Thursday, August 6th. The semiconductor company reported $1.06 EPS for the quarter, topping the consensus estimate of $0.89 by $0.17. Axcelis Technologies had a net margin of 10.71% and a return on equity of 11.69%. The company had revenue of $215.18 million during the quarter, compared to analysts’ expectations of $205.03 million. During the same quarter last year, the business earned $1.13 EPS. The business’s revenue was up 10.6% on a year-over-year basis. As a group, research analysts expect that Axcelis Technologies, Inc. will post 3.39 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have recently issued reports on ACLS shares. Weiss Ratings raised Axcelis Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, October 16th. Craig Hallum downgraded Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 price objective on the stock. in a report on Friday, August 7th. One research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $148.67.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc develops and manufactures equipment used in the fabrication of semiconductor devices. The company is best known for its ion implantation systems, which precisely introduce dopant atoms into silicon wafers to control the electrical properties of semiconductor components.

Its product portfolio includes the Purion family of ion implantation systems, designed for applications such as high-current, medium-current and high-energy implantation. Axcelis also provides related aftermarket products and services, including spare parts, equipment upgrades, process support and customer training.

Headquartered in Beverly, Massachusetts, Axcelis serves semiconductor manufacturers and other customers in major chip-production regions worldwide.